Premier Biomedical Release: CEO William Hartman Interviews On The Uptick Network Elaborating On Positive Plans For Continued Company Growth
El Paso, TX , Aug. 15, 2017 (GLOBE NEWSWIRE) -- CEO William Hartman Interviews on the Uptick Network Elaborating on Positive Plans for Continued Company Growth
El Paso, TX (UPTICK Newswire – August 15, 2017) – CEO William Hartman with Premier Biomedical (OTCQB:BIEI) was interviewed on the Uptick Network Stock Day Radio Show with host Everett Jolly. CEO Mr. William Hartman overviews the hold on Premier Biomedical’s R&D for its Biologics Division regarding cancer and PTSD, the promising results discovered by this division and discusses seeking partnership needed to continue these unique technologies. Mr. Hartman elaborates on the rapid expansion of Premier Biomedical’s mass production of its Hemp Oil products and the distribution of these products. Continuing the division expansion Mr. Hartman explains how Premier Biomedical is going to move forward with distributing its Hemp Oil products through Amazon. Mr. Hartman briefly mentions his plans to approach Medicare and insurance agencies for funding of their Hemp Oil products.
In closing, Mr. Hartman states, “We are considering expanding several products addressing human pain relief as well as products intended for use outside of the human pain relief arena.” Mr. Hartman continues, “What that says is we are an aggressive company, we are working as hard as we can, to develop all new products that are going to propel us into a whole different realm stock wise. We are vastly undervalued and we are doing everything we can to change our “makeup” and change our product lines so that they can become much more attractive to customers and stockholders.”
To read several miraculous voluntary testimonials regarding Premier Biomedical’s Hemp Oil products, go to https://painreliefmeds.com/blog/
To listen to the interview please go to http://www.premierbiomedical.com/wp-content/uploads/2017/08/Uptick-Network-BIEI-Interview-08-08-17.mp3
Or you can click: http://preview.tinyurl.com/yda46a22
To watch a video/slideshow presentation of Premier Biomedical's interview please visit: https://youtu.be/DA8A3GjLTqU
The interview was paid and approved by Premier Biomedical. The distribution was sent out to the Uptick Network Stock Day Radio show, sponsors, its affiliates and social media distribution platforms.
For further information please contact:
William A. Hartman
President and CEO
Premier Biomedical Inc.
(724) 633-7033
w.hartman@premierbiomedical.com
www.premierbiomedical.com
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (OTCQB: BIEI) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. Premier has obtained, via exclusive license agreements, the technology behind three granted US Patents, multiple pending provisional patents, and a PCT Europe National Patent. Founded in 2010, Premier has partnered with the Department of Defense with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP). The company’s R&D efforts are centered in El Paso, TX, and their business offices are in Western Pennsylvania. The Company is a fully-reporting issuer whose common stock trades on the OTCQB marketplace maintained by OTC Markets Group, Inc. under the ticker symbol “BIEI.” For more information please visit our website: www.premierbiomedical.com.
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
Source: Uptick Newswire
William A. Hartman President and CEO Premier Biomedical Inc. (724) 633-7033 w.hartman@premierbiomedical.com www.premierbiomedical.com